Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer.
Mengsi YuKainan ZhangSong WangLi XueZhaoyun ChenNing FengConghua NingLijuan WangJing LiBoke ZhangChangcheng YangZhaoxia ZhangPublished in: BioMed research international (2021)
Overexpression of SPHK1 and HAS2 could be important markers for the prognosis of pancreatic cancer.